Lupus, Race, and the Research Gap

Image of an african american woman lupus and the research gap

Lupus, Race, and the Research Gap: The Disease That Was Never Designed to Be Studied in Us: Lupus, Race, and the Research Gap

Image of an african american woman lupus and the research gap

Lupus is often called “the great imitator” because its symptoms—such as extreme fatigue, joint pain, and skin rashes—can resemble those of many other conditions.

But for African American women, lupus is more than a medical mystery; it is a systemic crisis. The relationship between lupus and black women is especially urgent because, for decades, the very treatments used to manage this disease were tested on populations that didn’t look like the women most affected by it. At Rooted in Violet & Co., we believe that advocacy is a form of healing. When we understand the gaps in the system, we can demand the care we deserve.

Lupus and Black Women by the Numbers: Why They Bear the Greatest Burden

The statistics surrounding Systemic Lupus Erythematosus (SLE) reveal a startling disparity. While lupus can affect anyone, it disproportionately targets young Black women.

  • Higher Prevalence: Approximately 1 in 537 young Black women are affected by lupus. This makes the disease 2 to 3 times more common in Black women than in White women.
  • Incidence Rates: Recent data show the incidence of SLE is 15.5 per 100,000, specifically among Black patients.
  • Mortality Gap: African Americans face a 2 to 3 times higher mortality rate from lupus. For Black and Hispanic females ages 15–24, lupus is the 5th leading cause of death.
  • Funding Disparity: Despite the heavy burden lupus places on the Black community, research funding from the National Institutes of Health (NIH) often fails to match the severity and prevalence of the disease.

The Biology and the Bias: What Drives Disparity?

The gap in health outcomes isn’t just about “bad luck.” It is a combination of biological differences, environmental stressors, and systemic bias.

Ancestry-Associated Immune Differences

Research suggests that there are ancestry-based differences in how our immune systems behave. For Black women, these “immune phenotypes” may contribute to more aggressive disease activity. This means the immune system isn’t just overactive; it’s acting in a way that specifically accelerates SLE in our bodies.

Discrimination as a Disease Driver

Stress isn’t just “in your head”—it’s in your blood. Studies like the BeWELL Study have shown that experiencing racial discrimination is directly linked to higher levels of C-Reactive Protein (CRP), a major marker of inflammation. This creates a dangerous “inflammation loop”:

  1. Systemic Stress/Discrimination → 2. Immune Activation → 3. Lupus Flare → 4. Increased Physical & Mental Stress.

Organ Damage and Vulnerability

Black women with lupus are more likely to experience faster organ damage, particularly in the kidneys (Lupus Nephritis). This risk is worsened when socioeconomic barriers—like lack of access to specialized care or affordable medication—prevent consistent disease management.

The Trial Gap: Tested on Everyone Except Us

One of the most significant hurdles in lupus care is the lack of representation in clinical trials.

  • The Disconnect: Black patients represent 43% of all lupus cases, yet they make up only 14% of clinical trial participants.
  • The Consequence: Because most lupus medications were approved based on data from White populations, we often don’t know if these drugs will be as effective—or as safe—for Black women until they are already on the market.

What Providers Miss: Clinical Bias and Delayed Diagnosis

On average, it can take six years for a person to receive an accurate lupus diagnosis. For Black women, this delay is often fueled by implicit bias. Doctors may dismiss joint pain as “soreness from work” or fatigue as “stress” or “weight-related,” rather than investigating an autoimmune cause.

Using the ROOT Framework™ for Lupus

You don’t have to wait for the system to change to get the care you need. Use the ROOT Framework™ to take control of your next appointment.

R – Reveal What’s Going On

Don’t minimize your pain. Track your symptoms (rashes, fevers, joint stiffness) in a journal.

  • The Script: “I have been tracking these butterfly-shaped rashes and joint pain for three months. I’d like to be screened for autoimmune conditions, specifically SLE. Can we run an ANA panel, anti-dsDNA, complement levels (C3/C4), and a CBC with differential?”

O – Offer Your Observations

Bring the facts about your risk factors to the table.

  • The Script: “As a Black woman, I know that lupus affects 1 in 537 women who look like me. I want to ensure we are ruling out autoimmune disease before we attribute these symptoms to general stress.”

O – Outline What You Need

Define your expectations for specialized care.

  • The Script: “I would like a referral to a rheumatologist. I also want to know my SLEDAI score (disease activity index) and what my current organ involvement status looks like.”

T – Take Note & Follow-Up

Document the plan and keep your records.

  • The Script: “To make sure I understand: you’re saying my ANA is positive but my anti-dsDNA is negative. What does that mean for my monitoring plan over the next six months?”

Plain-Language Takeaways

  • Lupus is 3x more common in Black women than in White women.
  • Discrimination and stress increase physical stress and inflammation markers in lupus.
  • Clinical trials rarely include enough Black participants, leading to “knowledge gaps” in treatment.
  • Self-advocacy is your right. Asking for specific blood tests (ANA, anti-dsDNA) is the first step toward a diagnosis.

🌿 Take the next step in your health journey: Access our Lupus Violet Sheet to help you track your symptoms and prepare for your rheumatology visit.

References

  • Allen, A. M., et al. (2023). Experiences of discrimination and systemic lupus erythematosus disease activity: The BeWELL study. Journal of Rheumatology.
  • Bylinska, A., et al. (2023). Ancestry-associated immune phenotype differences in systemic lupus erythematosus. JCI Insight.
  • Drenkard, C., et al. (2025). Racial differences in clinical trial perceptions among Black patients with SLE. Arthritis Care & Research.
  • Fike, A., et al. (2022). Incidence and prevalence of systemic lupus erythematosus among Black populations. Lupus Science & Medicine.
  • Lupus Foundation of America. (2024). Lupus facts and statistics.
  • Martz, K., et al. (2023). Socioeconomic resources and organ damage in Black women with systemic lupus erythematosus. Arthritis & Rheumatology.
  • Simard, J. F., et al. (2018). Black representation in lupus clinical trials: A systematic review. Arthritis & Rheumatology.